Trump administration issues order to separate childhood vaccines, raising public-health concerns
President Trump signed an executive order to split combined childhood vaccines into separate doses, a move experts say could increase missed appointments and lower immunization rates, with potential domestic and global repercussions.
President Donald Trump signed an executive order on Monday establishing the “Gold Standard Childhood Vaccine Recommendations,” which calls for separating combined childhood vaccines into individual administrations and revising school-entry vaccination requirements. The order proposes replacing the combined measles-mumps-rubella (MMR) vaccine with three separate shots and urges states to consider separate appointments for each vaccine "to the maximum extent feasible."
Public-health officials note that combination vaccines streamline immunization schedules and reduce the number of visits needed for children, thereby helping maintain high coverage rates. Requiring additional appointments could increase missed doses, particularly among families facing work, transportation, or childcare constraints, potentially leaving children vulnerable for longer periods.
The United States is currently experiencing a rise in measles cases, with 2,465 reported this year, the highest annual total in 35 years, after vaccination rates among kindergarteners fell below levels needed to prevent outbreaks. Two doses of the MMR vaccine remain about 97% effective against measles, but gaps in coverage allow the disease to spread.
Experts warn that the policy shift may undermine public confidence in vaccines and the institutions that evaluate them. They cite concerns that the order could fuel vaccine hesitancy, complicate clinician-patient discussions, and hinder outbreak response, especially as the Democratic Republic of the Congo confronts its largest Ebola outbreak and works on a new vaccine for the Bundibugyo virus.
The United States has historically contributed to global immunization efforts through funding and technical guidance. Changes to its vaccine policy could influence perceptions and practices in other countries that rely on American support for vaccine procurement and program design.
Analysts emphasize that maintaining easy access to proven vaccines and clear, evidence-based recommendations is essential to prevent disease resurgence and to sustain public trust in health authorities.